ArticleJournal of cancer research and clinical oncology2024

Risk assessment model based on nucleotide metabolism-related genes highlights SLC27A2 as a potential therapeutic target in breast cancer.

Bo Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.